Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Admir Vižlin
Institution:
University of Gothenburg
Observed institution:
University of Gothenburg
ORCID:
0009-0007-1087-7120
Observed ORCID:
0009-0007-1087-7120
OpenAlex ID:
A5104541643
Impact of Brodalumab on Serum Levels of IL-6, IL-17A, IFN-α, IFN-γ, and TNF-α in Patients with Psoriasis Who Failed Treatment with TNF-α Inhibitors
2026
·
Lucia Medjedovic
, Admir Vižlin
, et al.
·
International Journal of Molecular Sciences
·
4
PDF
No Evidence of Gut Microbiota Alteration in Psoriasis Patients Switching to Brodalumab after Loss of TNFα Inhibition Effect
2024
·
Admir Vižlin
, Ylva Andersch Björkman
, et al.
·
International Journal of Molecular Sciences
·
3
PDF
The Effects of Brodalumab on the Fungal Microbiome in Patients with Psoriasis
2024
·
Admir Vižlin
, Ajša Bajramović
, et al.
·
International Journal of Molecular Sciences
·
2
PDF
Serum and Fecal Calprotectin Levels Do Not Alter Significantly in Patients With Psoriasis Switching to Brodalumab After Loss of Effect From TNF‐α Inhibitors
2026
·
Admir Vižlin
, Hans‐Peter Claesson
, et al.
·
JEADV Clinical Practice
·
1
Show more works
View as search
Works count:
4
Citation count:
10
H-index:
2
I10-index:
Year
Topic
Type